Biotage signs a new agreement with PartnerTech

Biotage signs a new agreement with PartnerTech 

PartnerTech and Biotage, an international company in the field of life science
research, have expanded their cooperation and signed a new agreement to
manufacture instruments for DNA analysis and microwave synthesis. The agreement,
which runs for two years and renews automatically, is worth an estimated SEK 40
million annually. 


“PartnerTech's expertise and level of quality make us feel secure in assigning
them to handle our products” says Torben Jörgensen, President and CEO of
Biotage. “PartnerTech's product development division, which has helped make our
instruments even more competitive in a number of different ways, is also a very
big advantage for us.” 

Biotage has long collaborated with PartnerTech on the development and production
of its DNA instruments. The new agreement covers ongoing manufacture of current
products as well as serial production of a new DNA instrument that PartnerTech
developed. Thanks to close cooperation between the development units of the two
companies, the new instrument which fulfils the IVD-directive, is more
cost-effective to manufacture and offers higher performance. Biotage is served
by PartnerTech's customer center in Åtvidaberg, Sweden, which manufactures the
instrument. 
“PartnerTech has far-reaching expertise and a strong offering for the
manufacture of biomedical equipment that provide our customers with greater
value and security in the handling of their products,” says Rune Glavare,
President and CEO of PartnerTech. “We are glad that Biotage has decided to sign
a new contract with us, and we look forward to pursuing this successful
collaborative effort.”



For additional information, please call: 
Rune Glavare, President and CEO, PartnerTech AB, +46 (0) 706 20 24 54
Torben Jörgensen, President and CEO, Biotage AB, +46 (0)707-49 05 84


--------------------------------------------------------------------------------
----------------------------------------------
Biotage AB is an international company in the field of life science research.
The company provides solutions, expertise and experience in genetic analysis and
medicinal chemistry. Among its customers are the world's 30 biggest
pharmaceutical companies and 20 biggest biotech companies, as well as leading
academic institutions. Headquartered in Uppsala, Sweden, the company has
subsidiaries in the United States, Japan, the UK, Germany and several other
European countries. Biotage (www.biotage.com) has some 336 employees, reported
sales of SEK 496.4 million in 2007, and is listed on the OMX Nordic Exchange
Stockholm. 

PartnerTech AB develops and manufactures products under contract for leading
companies, primarily in telecommunications, IT, engineering and medical
technology. With some 1,700 employees at its plants in Sweden, Norway, Finland,
Poland, the UK, the United States and China, PartnerTech reports annual sales of
approximately SEK 2.6 billion. PartnerTech AB (www.partnertech.com), the parent
company, is headquartered in Malmö and listed on the OMX Nordic Exchange
Stockholm.

Information reported to the Swedish Financial Supervisory Authority
(Finansinspektionen)